Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma.
Seneviratne JA, Ravindrarajah D, Carter DR, Zhai V, Lalwani A, Krishan S, Balachandran A, Ng E, Pandher R, Wong M, Nero TL, Wang S, Norris MD, Haber M, Liu T, Parker MW, Cheung BB, Marshall GM.
Seneviratne JA, et al.
Cancer Med. 2024 Nov;13(21):e70082. doi: 10.1002/cam4.70082.
Cancer Med. 2024.
PMID: 39501501